#neurocrine-biosciences (1 Posts)
-
Neurocrine's New CAH Drug, Krenicity, Gets FDA Approval—Here’s What You Need to Know FDA approves Neurocrine Biosciences' Krenicity for congenital adrenal hyperplasia, reducing glucocorticoid dosage in patients.
Hot Topics